NOVT.NASDAQNovanta INC

Form 4: Novanta Director Mary Kay Ladone Reports Future RSU Settlement into Common Shares

Sentiment:

Insider Transaction Report


Novanta Inc. Director Mary Kay Ladone has filed a Form 4 indicating the future settlement of 572 Restricted Stock Units into common shares on July 11, 2025.

Summary

  • Mary Kay Ladone, a Director of Novanta Inc. (NOVT), reported a transaction involving the settlement of Restricted Stock Units (RSUs).
  • On July 11, 2025, 572 RSUs, each equivalent to one Novanta Inc. common share, will be settled.
  • This transaction will result in the acquisition of 572 common shares and the disposition of 572 RSUs.
  • Following this transaction, Mary Kay Ladone will beneficially own 572 common shares directly and 0 derivative securities (RSUs).

Sentiment

Score: 5

Explanation: The transaction is a routine settlement of Restricted Stock Units, which is a neutral event in terms of company performance or outlook. It represents the vesting of previously granted equity compensation.

Positives

  • The settlement of Restricted Stock Units into common shares indicates the vesting of previously granted equity compensation, aligning the director's interests with shareholders.

Negatives

  • No inherently negative aspects are present in this routine RSU settlement.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to equity compensation, common across all industries for public company directors and executives. It does not reflect broader industry trends.

Stakeholder Impact

  • Shareholders: The transaction increases the director's direct ownership of common shares, aligning their interests with other shareholders. The issuance of 572 shares is a very minor dilution.

Key Dates

DateDescription
07/11/2025Date of earliest transaction, when 572 Restricted Stock Units will be settled into Novanta Inc. common shares.
07/14/2025Date the Form 4 filing was signed by John Burke, Attorney-in-Fact for Mary Kay Ladone.

Keywords

Novanta Inc., NOVT, Form 4, SEC Filing, Restricted Stock Units, RSU, Common Stock, Insider Transaction, Director, Equity Compensation, Share Settlement

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.